← Leaderboards
John Shern
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Genetic”
- Richard A Gibbs · Baylor College Of Medicine$577,061,667
- Eric S Lander · Whitehead Institute For Biomedical Res$560,806,052
- David R. Weir · University Of Michigan At Ann Arbor$322,225,557
- Richard K. Wilson · Washington University$316,685,275
- Lawrence Corey · Fred Hutchinson Cancer Center$312,182,347
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$302,429,647
Research focus
GeneticTumorGenomicsGenesWhole GenomeEpigenetic ProcessSamplingCellsClinical TrialsNeurofibrosarcomaOperative Surgical ProceduresFoxo1a GeneRhabdomyosarcomaNf1 GeneGenetic TranscriptionResponseMortalityBiological ModelsRelapseMutationBaseComplexPlexiform NeurofibromaPre-Clinical Model
Grant awards (20)
Genomic dissection of tumor heterogeneity and progression$927,446
ZIA · FY2025 · CA · contact PI
Genomic characterization and development of therapies for pediatric sarcoma$927,446
ZIA · FY2025 · CA · contact PI
Genomic dissection of tumor heterogeneity and progression$904,989
ZIA · FY2024 · CA · contact PI
Genomic characterization and development of therapies for pediatric sarcoma$904,989
ZIA · FY2024 · CA · contact PI
Genomic characterization and development of therapies for pediatric sarcoma$872,696
ZIA · FY2023 · CA · contact PI
Genomic dissection of tumor heterogeneity and progression$872,696
ZIA · FY2023 · CA · contact PI
Genomic dissection of tumor heterogeneity and progression$761,986
ZIA · FY2022 · CA · contact PI
Genomic characterization and development of therapies for pediatric sarcoma$761,986
ZIA · FY2022 · CA · contact PI
Genomic characterization and development of therapies for pediatric sarcoma$760,170
ZIA · FY2021 · CA · contact PI
Genomic dissection of tumor heterogeneity and progression$760,170
ZIA · FY2021 · CA · contact PI
Genomic dissection of tumor heterogeneity and progression$743,763
ZIA · FY2020 · CA · contact PI
Genomic characterization and development of therapies for pediatric sarcoma$743,763
ZIA · FY2020 · CA · contact PI
Genomic characterization and development of therapies for pediatric sarcoma$801,360
ZIA · FY2019 · CA · contact PI
Genomic dissection of tumor heterogeneity and progression$801,360
ZIA · FY2019 · CA · contact PI
Genomic dissection of tumor heterogeneity and progression$551,809
ZIA · FY2018 · CA · contact PI
Genomic characterization and development of therapies for Rhabdomyosarcoma$551,809
ZIA · FY2018 · CA · contact PI
Genomic dissection of tumor heterogeneity and progression$294,563
ZIA · FY2017 · CA · contact PI
Genomic characterization and development of therapies for Rhabdomyosarcoma$294,563
ZIA · FY2017 · CA · contact PI
Genomic dissection of tumor heterogeneity and progression$206,027
ZIA · FY2016 · CA · contact PI
Genomic characterization and development of therapies for Rhabdomyosarcoma$206,027
ZIA · FY2016 · CA · contact PI